Central Bureau of Narcotics (CBN) India thwarts illegal trafficking of 12 crore Tramadol Hydrochloride, a.k.a. “fighter drug” tablets under “Operation Vajra”

1. At a Glance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

Item Detail
Nodal agency Central Bureau of Narcotics (CBN) [S1]
Parent department Department of Revenue (DoR), Ministry of Finance [S1]
Operation name "Operation Vajra" [S1]
Substance seized Tramadol Hydrochloride, 250 mg tablets ("fighter drug") [S1]
Quantity 12 crore (120 million) tablets, ~30 metric tons (30,000 kg) [S1]
Seizure location Warehouse in Delhi [S1]
Arrests 3 persons — 1 Bengaluru, 2 Kochi [S1]
Declared export destination Guinea-Bissau (West Africa) [S1]
Suspected actual destination Libya [S1]
Governing law NDPS Act, 1985; Section 8(c) restricts psychotropic substance export [S2]
Substance notified as psychotropic 2018 [S2]
CBN headquarters Gwalior, Madhya Pradesh

5. Multi-Dimensional Analysis

Geopolitical / Strategic - Highlights India's exposure as a pharmaceutical/API export hub being exploited for diversion to conflict zones (Libya) via transshipment routes (Guinea-Bissau) [S1]. - Reinforces India's cooperation obligations under UN drug control conventions and engagement with bodies like the International Narcotics Control Board (INCB) on precursor/psychotropic diversion monitoring.

Legal / Constitutional - Anchored in the NDPS Act, 1985, specifically Section 8(c) governing export restrictions on psychotropic substances [S2]. - Demonstrates enforcement of the 2018 notification bringing Tramadol under statutory psychotropic control [S2].

Administrative - Interagency coordination across CBN units and regional intelligence (arrests spanning Bengaluru, Kochi, seizure in Delhi) shows the pan-India, multi-city nature of narcotics enforcement operations [S1]. - CBN, though under the Finance Ministry (Revenue), operates in tandem with police/other narcotics agencies (NCB) for such transnational trafficking cases.

Social - Tramadol abuse and diversion for war-zone/combatant use (ISIS-linked usage) underscores the narco-terror–conflict nexus, distinct from typical recreational drug abuse concerns [S2].

Economic - Misuse of legitimate pharmaceutical export documentation/EXIM channels for large-volume (30 MT) diversion raises concerns about regulatory gaps in pharma export oversight.

6. Recent Developments (last 12–18 months)

7. Prelims Hooks

8. Mains Relevance

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources